Deutsche Märkte schließen in 3 Stunden 19 Minuten

Sartorius Aktiengesellschaft (SRT.DE)

XETRA - XETRA Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
224,00-2,50 (-1,11%)
Ab 01:36PM CEST. Markt geöffnet.

Sartorius Aktiengesellschaft

Otto-Brenner-Strasse 20
Göttingen 37079
Germany
49 551 308 0
https://www.sartorius.com

Sektor(en): Healthcare
Branche: Medical Instruments & Supplies
Vollzeitmitarbeiter: 14.614

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Dr. Joachim KreuzburgChairman of Executive Board & CEO1,07MN/A1965
Dr. Rene FaberHead of Bioprocess Solutions Division & Member of Executive Board613kN/A1975
Dr. Alexandra GatzemeyerHead of the Lab Products & Services Division and Member of Executive Board537kN/AN/A
Ms. Petra KirchhoffHead of Corporate Communications & Investor Relations and Member of Supervisory Board82kN/A1969
Dr. Florian Funck Dipl.Kfm.CFO & Member of Executive BoardN/AN/A1971
Ms. Patricia SpannagelHead of Quality Assurance - Mechatronics Division GoettingenN/AN/AN/A
Ralf MohrschladtPhysicist & Head of Supply Chain Management - GermanyN/AN/AN/A
Ms. Petra MullerHead of Investor RelationsN/AN/AN/A
Mr. Maurice PhelanPresident of Sartorius North AmericaN/AN/AN/A
Dr. Theo ThijssenPresident of Environmental Technology DivisionN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Corporate Governance

Sartorius Aktiengesellschafts ISS Governance QualityScore, Stand 1. April 2024, lautet 9. Die grundlegenden Scores sind Audit: 3, Vorstand: 6, Shareholderrechte: 10, Kompensation: 9.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.